Neumora Therapeutics, Inc. Common Stock
NMRANASDAQHealthcare● Active
$1.62
$-0.01(-0.90%)
Market Cap$299308161
P/E Ratio—
52W High$3.65
52W Low$0.716
Neumora Therapeutics, Inc. Common Stock（NMRA）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · NMRA · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Cost of Revenue | $0.01B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | ($0.01B) | $0.00B | ($0.00B) | $0.00B | $0.00B |
| Gross Margin %(computed) | — | — | — | — | — |
| Operating Expenses | |||||
| R&D Expenses | $0.18B | $0.20B | $0.14B | $0.10B | $0.21B |
| G&A Expenses | $0.06B | $0.06B | $0.05B | $0.03B | $0.02B |
| Total Operating Expenses | $0.24B | $0.26B | $0.19B | $0.14B | $0.24B |
| Operating Income | ($0.24B) | ($0.26B) | ($0.19B) | ($0.14B) | ($0.24B) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $0.01B | $0.02B | $0.02B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.24B) | ($0.24B) | ($0.24B) | ($0.13B) | ($0.24B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.24B) | ($0.24B) | ($0.24B) | ($0.13B) | ($0.24B) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.45 | $-1.53 | $-1.49 | $-0.86 | $-1.56 |
| Wtd Avg Shares | 0.16B | 0.16B | 0.16B | 0.15B | 0.15B |
| EBITDA | ($0.23B) | ($0.26B) | ($0.19B) | ($0.14B) | ($0.24B) |
| EBITDA Margin %(computed) | — | — | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · B
深入了解Neumora Therapeutics, Inc. Common Stock
关于Neumora Therapeutics, Inc. Common Stock（NMRA）损益表
Neumora Therapeutics, Inc. Common Stock（NMRA）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，NMRA实现营收$0.00B，毛利润($0.01B)（毛利率—），净利润($0.24B)（净利率—）。
常见问题
NMRA · 4 问Neumora Therapeutics, Inc. Common Stock（NMRA）2025财年营收为$0.00B，同比down—%。
NMRA revenueNMRA salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08